TrialDiabetes care2010

Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent.

Paolo Gresele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.